IDO1 and pituitary gland adenoma: This finding shows that, in this case–control setting, each one-unit increase in IDO, kynurenic acid, and kynurenine levels is associated with 2.74-fold, 1.16-fold, and 1.10-fold higher odds of being in the pituitary adenoma group rather than the control group, respectively.